# OnCo record oncomine-dx-express (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/oncomine-dx-express/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "oncomine-dx-express" ;
  schema:name "Oncomine Dx Express Test"@en ;
  schema:description "Thermo Fisher's newer sequencing test for lung cancer, companion to sunvozertinib for EGFR exon 20 insertions and to sevabertinib for HER2 mutations."@en ;
  schema:url <https://onco.cc/drugs/oncomine-dx-express/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P240040>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "Tissue NGS companion diagnostic test" ;
  schema:alternateName "Oncomine Dx Express Test" ;
  onco:approval "US 2025: Companion diagnostic for sunvozertinib in NSCLC with EGFR exon 20 insertions", "US 2026: Companion diagnostic for sevabertinib in NSCLC with HER2 activating mutations" ;
  onco:related <https://onco.cc/drugs/oncomine-dx-target-test/>, <https://onco.cc/biomarkers/egfr-exon-20-insertion/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/sunvozertinib/>, <https://onco.cc/drugs/sevabertinib/> ;
  onco:companies <https://onco.cc/companies/life-technologies/> ;
  onco:terms <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/companion-diagnostic-term/> .